1-3 of 3
Leighton E. Clancy
Close
Sort by
Journal Articles

Third-party CMV- and EBV-specific T-cells for first viral reactivation after allogeneic stem cell transplant

Wei Jiang, Leighton E. Clancy, Selmir Avdic, Gaurav Sutrave, Janine Street, Renee Simms, Helen M. McGuire, Ellis Patrick, Adam S. Chan, Georgia McCaughan, Nadav Myers, Kenneth P. Micklethwaite, Vicki Antonenas, Adrian G. Selim, David Ritchie, Caroline M. Bateman, Peter J. Shaw, Emily Blyth, David J. Gottlieb
Journal: Blood Advances
Blood Adv (2022) 6 (17): 4949–4966.
https://doi.org/10.1182/bloodadvances.2022007103
Published: 2022
Includes: Supplemental data
Journal Articles

Rapidly expanded partially HLA DRB1–matched fungus-specific T cells mediate in vitro and in vivo antifungal activity

Gloria Castellano-González, Helen M. McGuire, Fabio Luciani, Leighton E. Clancy, Ziduo Li, Selmir Avdic, Brendan Hughes, Mandeep Singh, Barbara Fazekas de St Groth, Giorgia Renga, Marilena Pariano, Marina M. Bellet, Luigina Romani, David J. Gottlieb
Journal: Blood Advances
Blood Adv (2020) 4 (14): 3443–3456.
https://doi.org/10.1182/bloodadvances.2020001565
Published: 2020
Includes: Supplemental data
Journal Articles

Long-term control of recurrent or refractory viral infections after allogeneic HSCT with third-party virus-specific T cells

Clinical Trials & Observations
Barbara Withers, Emily Blyth, Leighton E. Clancy, Agnes Yong, Chris Fraser, Jane Burgess, Renee Simms, Rebecca Brown, David Kliman, Ming-Celine Dubosq, David Bishop, Gaurav Sutrave, Chun Kei Kris Ma, Peter J. Shaw, Kenneth P. Micklethwaite, David J. Gottlieb
Journal: Blood Advances
Blood Adv (2017) 1 (24): 2193–2205.
https://doi.org/10.1182/bloodadvances.2017010223
Published: 2017
Includes: Supplemental data